🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The general aim of the current study was to investigate the safety and tole...
Status
Completed
Location
Multiple Locations
Start Date
2010-03
Trial ID
NCT02224105
Enterobacterieaceae (and specially Escherichia coli) showing resistance due...
Status
Completed
Location
Hospital Mutua de Terrassa
Start Date
2014-07
Trial ID
NCT02142751
Treatments Being Tested
This is a single center, open-label phase1b clinical trial. The study will ...
Status
Completed
Location
Suining County Center for Disease Control and Prevention
Start Date
2019-05-16
Trial ID
NCT03966040
Treatments Being Tested
The aim of the investigators' study was to evaluate oral and non carbapenem...
Status
Unknown
Location
Faculty of Medicine Ramathibodi Hospital
Start Date
2012-11
Trial ID
NCT02537847
Treatments Being Tested
This study will include a screening period, a 6-month treatment period, fol...
Status
Completed
Location
Children's Hospital of Wisconsin
Start Date
2014-04
Trial ID
NCT02047461
Treatments Being Tested
The purpose of this study is to measure the safety and explore the efficacy...
Status
Not Yet Recruiting
Location
HonorHealth Research Institute
Start Date
2026-04
Trial ID
NCT07559175
Purpose: The overall purpose of this study is to evaluate the impact of a s...
Status
Completed
Location
UNC Carolina Population Center
Start Date
2023-11-28
Trial ID
NCT06119165
Treatments Being Tested
The goal of this study is to determine whether eco-labels denoting more sus...
Status
Completed
Location
Harvard Pilgrim Health Care Institute
Start Date
2024-09-30
Trial ID
NCT06584539
Treatments Being Tested
The aim of this study is to compare responses to 5 different types of label...
Status
Completed
Location
Stanford School of Medicine
Start Date
2023-08-07
Trial ID
NCT05953246
This phase I trial tests the safety, side effects, and best dose of calaspa...
Status
Completed
Location
OHSU Knight Cancer Institute
Start Date
2022-08-09
Trial ID
NCT05034627
Treatments Being Tested